share_log

RBC Capital Reiterates Outperform on Insmed, Maintains $100 Price Target

Benzinga ·  Mar 19 14:40

RBC Capital analyst Leonid Timashev reiterates Insmed (NASDAQ:INSM) with a Outperform and maintains $100 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
Comment Comment · Views 251

Recommended

Write a comment